DRRX DURECT CORP Earnings Calls 8-K Filing 2023 - Other Events DURECT Corp announced topline results from its AHFIRM trial for larsucosterol in patients with severe alcohol-associated hepatitis and will conduct a webcast to present the results.Get access to all SEC 8-K filings of the DURECT CORP